These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 20851614

  • 1. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C, Czollner L, Koller I, Shah P, Gaware R, Cunha TD, Odermatt A, Jordis U, Kosma P, Classen-Houben D.
    Bioorg Med Chem; 2010 Nov 01; 18(21):7522-41. PubMed ID: 20851614
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Gaware R, Khunt R, Czollner L, Stanetty C, Da Cunha T, Kratschmar DV, Odermatt A, Kosma P, Jordis U, Classen-Houben D.
    Bioorg Med Chem; 2011 Mar 15; 19(6):1866-80. PubMed ID: 21376605
    [Abstract] [Full Text] [Related]

  • 3. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV, Vuorinen A, Da Cunha T, Wolber G, Classen-Houben D, Doblhoff O, Schuster D, Odermatt A.
    J Steroid Biochem Mol Biol; 2011 May 15; 125(1-2):129-42. PubMed ID: 21236343
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid.
    Classen-Houben D, Schuster D, Da Cunha T, Odermatt A, Wolber G, Jordis U, Kueenburg B.
    J Steroid Biochem Mol Biol; 2009 Feb 15; 113(3-5):248-52. PubMed ID: 19429429
    [Abstract] [Full Text] [Related]

  • 5. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
    Roche D, Carniato D, Leriche C, Lepifre F, Christmann-Franck S, Graedler U, Charon C, Bozec S, Doare L, Schmidlin F, Lecomte M, Valeur E.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2674-8. PubMed ID: 19395260
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group.
    Kwon SW, Kang SK, Lee JH, Bok JH, Kim CH, Dal Rhee S, Jung WH, Kim HY, Bae MA, Song JS, Ha DC, Cheon HG, Kim KY, Ahn JH.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):435-9. PubMed ID: 21093259
    [Abstract] [Full Text] [Related]

  • 7. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y, Yokokawa A, Takashima S, Shibasaki H, Furuta T.
    Steroids; 2005 Feb 01; 70(2):117-25. PubMed ID: 15631868
    [Abstract] [Full Text] [Related]

  • 8. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ, Latif SA, Hardy MP, Brem AS.
    J Steroid Biochem Mol Biol; 2007 May 01; 104(3-5):161-8. PubMed ID: 17459698
    [Abstract] [Full Text] [Related]

  • 9. A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2.
    Vicker N, Su X, Lawrence H, Cruttenden A, Purohit A, Reed MJ, Potter BV.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3263-7. PubMed ID: 15149687
    [Abstract] [Full Text] [Related]

  • 10. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases.
    Su X, Lawrence H, Ganeshapillai D, Cruttenden A, Purohit A, Reed MJ, Vicker N, Potter BV.
    Bioorg Med Chem; 2004 Aug 15; 12(16):4439-57. PubMed ID: 15265495
    [Abstract] [Full Text] [Related]

  • 11. Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11beta-hydroxysteroid dehydrogenase 2.
    Kim CH, Cho YS.
    Cell Biochem Funct; 2010 Aug 15; 28(6):440-7. PubMed ID: 20629036
    [Abstract] [Full Text] [Related]

  • 12. Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
    Lin H, Hu GX, Guo J, Ge Y, Liang G, Lian QQ, Chu Y, Yuan X, Huang P, Ge RS.
    Bioorg Med Chem Lett; 2013 Aug 01; 23(15):4362-6. PubMed ID: 23800686
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives.
    Su X, Vicker N, Lawrence H, Smith A, Purohit A, Reed MJ, Potter BV.
    J Steroid Biochem Mol Biol; 2007 May 01; 104(3-5):312-20. PubMed ID: 17493801
    [Abstract] [Full Text] [Related]

  • 14. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
    Latif SA, Pardo HA, Hardy MP, Morris DJ.
    Mol Cell Endocrinol; 2005 Nov 24; 243(1-2):43-50. PubMed ID: 16188377
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements.
    Yeh VS, Kurukulasuriya R, Madar D, Patel JR, Fung S, Monzon K, Chiou W, Wang J, Jacobson P, Sham HL, Link JT.
    Bioorg Med Chem Lett; 2006 Oct 15; 16(20):5408-13. PubMed ID: 16890427
    [Abstract] [Full Text] [Related]

  • 16. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
    Su X, Pradaux-Caggiano F, Thomas MP, Szeto MW, Halem HA, Culler MD, Vicker N, Potter BV.
    ChemMedChem; 2010 Jul 05; 5(7):1026-44. PubMed ID: 20486152
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of sulfonamidooxazoles and beta-keto sulfones: selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
    Xiang J, Ipek M, Suri V, Massefski W, Pan N, Ge Y, Tam M, Xing Y, Tobin JF, Xu X, Tam S.
    Bioorg Med Chem Lett; 2005 Jun 02; 15(11):2865-9. PubMed ID: 15911270
    [Abstract] [Full Text] [Related]

  • 18. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
    Yang H, Dou W, Lou J, Leng Y, Shen J.
    Bioorg Med Chem Lett; 2008 Feb 15; 18(4):1340-5. PubMed ID: 18242087
    [Abstract] [Full Text] [Related]

  • 19. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
    Webster SP, Ward P, Binnie M, Craigie E, McConnell KM, Sooy K, Vinter A, Seckl JR, Walker BR.
    Bioorg Med Chem Lett; 2007 May 15; 17(10):2838-43. PubMed ID: 17350260
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors.
    Yeh VS, Patel JR, Yong H, Kurukulasuriya R, Fung S, Monzon K, Chiou W, Wang J, Stolarik D, Imade H, Beno D, Brune M, Jacobson P, Sham H, Link JT.
    Bioorg Med Chem Lett; 2006 Oct 15; 16(20):5414-9. PubMed ID: 16899366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.